Results of a clinical study called PANGEA (Personalized ANtibodies for GastroEsophageal Adenocarcinoma) found survival benefits for patients when compared to [...]
About Mindy Mintz MordecaiThis author has not yet filled in any details.
So far Mindy Mintz Mordecai has created 14 blog entries.
A message from ECAN's founder: My husband’s birthday came this week. And this year, for the first time since he [...]
The early results of two large, Phase III clinical trials of the immunotherapy Opdivo (nivolumab) showed significant survival benefits for [...]
The familial connection is one of the Strongest Indicators of Risk according to Experts. ECAN spoke with the Leading Researcher [...]
First Time the FDA has given Breakthrough Designation for a Device Targeting Diseases of the Esophagus. Lucid Diagnostics' EsoGuard™ Esophageal [...]
ECAN thanks everyone who donated or raised funds to support our medical research campaign on #GivingTuesday! You and the rest [...]
Thanksgiving is during GERD Awareness Week! Show your gratitude by sharing a life-saving message with someone you are thankful for! [...]
Late last month, news broke that Rock Star Eddie Money was diagnosed with Stage IV Esophageal Cancer in the fall [...]
ECAN Advocates Convince Congress to Include Esophageal Cancer in a Multi-Million Dollar Research Fund
Now it's Time to Do It Again! Thanks to thousands in the ECAN family, for the first time in history, [...]
The U.S. Food and Drug Administration has approved Keytruda (Pembrolizumab) for treatment of advanced Esophageal Squamous Cell Carcinoma (ESCC). It [...]